These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1808859)

  • 1. [Factors affecting correct use of metered dose aerosols].
    Sprossmann A; Kutschka F; Enk M; Bergmann KC
    Z Erkr Atmungsorgane; 1991; 177(1-2):93-5. PubMed ID: 1808859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of causes of incorrect use of dose aerosols].
    Petro W; Gebert P; Lauber B
    Pneumologie; 1994 Mar; 48(3):191-6. PubMed ID: 8197077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of demonstration and role of the pharmacist in teaching the correct use of pressurized bronchodilators.
    Self TH; Brooks JB; Lieberman P; Ryan MR
    Can Med Assoc J; 1983 Jan; 128(2):129-31. PubMed ID: 6848154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Errors committed in using dosed aerosols in patients with obstructive lesions].
    Stoicescu P; Mirion R; Puşcariu C; Ionescu AA
    Pneumoftiziologia; 1993; 42(1-2):7-9. PubMed ID: 8142762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaler and spacer use in obstructive airway diseases.
    Jones MD; Yeager H
    Am Fam Physician; 1990 Oct; 42(4):1007-13. PubMed ID: 2220509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

  • 8. Survey of the clinical use of pressurized aerosol inhalers.
    Epstein SW; Manning CP; Ashley MJ; Corey PN
    Can Med Assoc J; 1979 Apr; 120(7):813-6. PubMed ID: 427689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aerosol generation and delivery systems for pulmonary drug administration: theory and practice].
    Newhouse MT
    Z Gesamte Inn Med; 1993 Aug; 48(8):363-8. PubMed ID: 8379217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different inhalation modes on the efficacy of pressurized aerosol bronchodilators.
    Clarke SW; Pavia D; Newman SP
    Eur J Respir Dis Suppl; 1982; 119():79-88. PubMed ID: 6954091
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance with aerosol therapy in chronic obstructive lung disease.
    Chryssidis E; Frewin DB; Frith PA; Dawes ER
    N Z Med J; 1981 Nov; 94(696):375-7. PubMed ID: 6948205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on inhalation therapy in asthma and obstructive bronchopulmonary diseases].
    Boulet LP; d'Amours P; Bérubé D; Rouleau M; Parent JG; Pelletier C; Touchette C
    Union Med Can; 1994 Jan; 123(1):23-31. PubMed ID: 8109063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endobronchial bronchodilators].
    Yernault JC
    Rev Med Brux; 1994; 15(4):277, 280-1. PubMed ID: 7939004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of a combination of fluticasone and salmeterol in patients with obstructive airway diseases. DUO Study Group].
    Wiewrodt R; Dauletbaev N; Buhl R
    Pneumologie; 1998 Jan; 52(1):14-20. PubMed ID: 9540365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearing the mist from our eyes: bronchodilators, mechanical ventilation, new devices, locations, and what you should know about bias flow.
    Diblasi RM
    Respir Care; 2010 Jul; 55(7):942-6. PubMed ID: 20587109
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aerosol therapy of patients with lung diseases].
    Kokosov AN; Potashev DA
    Klin Med (Mosk); 1988 Dec; 66(12):108-13. PubMed ID: 3230841
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aerosol therapy in obstructive respiratory tract diseases: deposition, administration methods, inhalation technics, inhalation aids].
    Niggemann B
    Ergeb Inn Med Kinderheilkd; 1989; 59():169-212. PubMed ID: 2686974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.